This trial is to see if a third dose of the HPV vaccine is necessary for people aged 15-26, or if two doses provide enough protection against the nine types of HPV it vaccinates against.
- Human Papillomavirus
18 Primary · 0 Secondary · Reporting Duration: Month 12
4 Treatment Groups
Females, 3 dose standard
1 of 4
Males, 3 dose standard
1 of 4
Females, 2 dose with delayed 3rd dose
1 of 4
Males, 2 dose with delayed 3rd dose
1 of 4
800 Total Participants · 4 Treatment Groups
Primary Treatment: 9-valent HPV vaccine, 2 dose efficacy · No Placebo Group · Phase 4
Who is running the clinical trial?
Age 15 - 26 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are currently receiving treatments as part of this experiment?
"Affirmative. Research hosted on clinicaltrials.gov reveals that this medical research project, which was first published on June 17th 2019, is actively recruiting patients at present. The trial necessitates the enrollment of 700 participants from 1 location." - Anonymous Online Contributor
Has the two-dose 9-valent HPV vaccine been verified by the FDA for efficacy?
"The 9-valent HPV vaccine, 2 dose efficacy has gotten a score of 3 due to the Phase 4 classification; which denotes that it is officially approved." - Anonymous Online Contributor
What are the eligibility requirements for this research trial?
"This clinical trial is enrolling 700 participants aged between 15-26 that have yet to receive any immunizations. Furthermore, applicants must possess reliable telephone access and an identified source of funding for the vaccine such as Texas Vaccines for Children (VFC) program, Medicaid, the Children's Health Insurance Plan (CHIP), Texas Healthy Women programme or other public or private health insurance. To verify prior vaccination history we will consult with patients' primary care provider in addition to Immtrac and UTMB electronic medical record if they had been seen at UTMB before." - Anonymous Online Contributor
Does the trial permit individuals of younger ages to participate?
"This clinical trial seeks participants aged between 15 and 26 years old." - Anonymous Online Contributor
Is there still room for participants in this clinical experiment?
"Per the information presented on clinicaltrials.gov, this trial is currently seeking participants. The study had its inception on June 17th 2019 and has been recently amended as of October 5th 2022." - Anonymous Online Contributor